FAES Farma and Invida (a Menarini Group Company) Announce Agreement to Commercialize Bilastine in 17 Markets in Asia – Pacific
4/27/2012 10:01:27 AM
More...
|
Teijin Pharma and Menarini Group Conclude Distribution Agreement for febuxostat in Central and South America, CIS and Oceania
4/11/2012 8:43:32 AM
More...
|
Moberg Derma and Menarini Group Sign Agreement for Emtrix in Italy
12/9/2011 6:22:56 AM
More...
|
Menarini Group Succeeds in Bid for Invida
11/15/2011 6:32:14 AM
More...
|
Launch by Menarini Group And Ipsen of ADENURIC(R) (febuxostat) in France for the Treatment of Chronic Hyperuricemia in Gout
3/5/2010 8:37:24 AM
More...
|
Nanogen, Inc. (NGEN) Partners With Menarini Group to Capture European Molecular Diagnostic Market
11/7/2008 11:11:53 AM
More...
|
Solagran Announce Proposed Strategic Alliance with Menarini Group
1/31/2008 11:49:29 AM
More...
|
Goodwin Biotechnology, Inc. and Menarini Group Announce the Successful Completion of Their Strategic US-Italian Cooperation to Fight Ovarian Cancer
7/10/2007 12:00:22 PM
More...
|
Spectral Diagnostics (SDI.TO) and Menarini Sign European EAA(TM) Distribution Agreement
5/22/2007 2:39:22 PM
More...
|
Oscient Pharmaceuticals Corporation (OSCI) And Menarini Group Enter Into European Commercialization Agreement For FACTIVE Tablets
1/4/2007 10:37:22 AM
More...
|
|